Literature DB >> 1624955

Computational simulations of the conformational behaviour of the adhesive proteins RGDS fragment.

M Cotrait1, M Kreissler, J Hoflack, J M Lehn, B Maigret.   

Abstract

Many adhesive proteins present in extracellular matrices and in blood contain the tetrapeptide sequence -Arg-Gly-Asp-Ser- (or RGDS) at their cell recognition site. Since this sequence, or similar ones, was found in many proteins involved in major biological mechanisms, conformational investigations were performed on the RGDS fragment. A preliminary review of available crystal structures indicates that the RxDy sequences exhibit 3 well-defined structural patterns: one corresponding to a strong interaction between the Arg and Asp ionic side chains which are only about 4 A apart, one with the ions separated by about 8 A, and another in which the side chains are further apart (about 11 A). The conformational behaviour of the isolated RGDS fragment was next tackled using sequential building, Monte Carlo and molecular dynamics computational techniques. Analysis of the RGDS sequence conformational possibilities, as simulated in vacuum and in water solution, indicates that they can be classified into several conformational classes, which correspond roughly to the behaviour of the RGDS fragment as observed in protein matrices. This suggests the possibility of understanding the biological role of the RGDS or parent sequences in recognition processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624955     DOI: 10.1007/bf00129423

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  27 in total

1.  Conformational sampling using high-temperature molecular dynamics.

Authors:  R E Bruccoleri; M Karplus
Journal:  Biopolymers       Date:  1990-12       Impact factor: 2.505

2.  High directional Monte Carlo procedure coupled with the temperature heating and annealing as a method to obtain the global energy minimum structure of polypeptides and proteins.

Authors:  J K Shin; M S Jhon
Journal:  Biopolymers       Date:  1991-02-05       Impact factor: 2.505

3.  Strength and co-operativity of contributions of surface salt bridges to protein stability.

Authors:  A Horovitz; L Serrano; B Avron; M Bycroft; A R Fersht
Journal:  J Mol Biol       Date:  1990-12-20       Impact factor: 5.469

Review 4.  Integrins.

Authors:  E Ruoslahti
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 5.  Fibronectins.

Authors:  R O Hynes
Journal:  Sci Am       Date:  1986-06       Impact factor: 2.142

Review 6.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

7.  The cell attachment domain of fibronectin. Determination of the primary structure.

Authors:  M D Pierschbacher; E Ruoslahti; J Sundelin; P Lind; P A Peterson
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

8.  Nanosecond time scale folding dynamics of a pentapeptide in water.

Authors:  D J Tobias; J E Mertz; C L Brooks
Journal:  Biochemistry       Date:  1991-06-18       Impact factor: 3.162

9.  Structure of the fibrinogen binding sequence: arginylglycylaspartic acid (RGD).

Authors:  D S Eggleston; S H Feldman
Journal:  Int J Pept Protein Res       Date:  1990-08

10.  An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion.

Authors:  R Bar-Shavit; V Sabbah; M G Lampugnani; P C Marchisio; J W Fenton; I Vlodavsky; E Dejana
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

View more
  2 in total

1.  Elucidation of a common structure of selective fibrinogen receptor antagonists.

Authors:  H Minoux; N Moitessier; Y Chapleur; B Maigret
Journal:  J Comput Aided Mol Des       Date:  1998-11       Impact factor: 3.686

2.  Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.

Authors:  G Müller; M Gurrath; H Kessler
Journal:  J Comput Aided Mol Des       Date:  1994-12       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.